Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique

Autor: A. M. W. Van Den Ouweland, Arie P. T. Smits, A. de Haan, Hans Galjaard, H.M. van Beerendonk, S. Mohkamsing, Erik A. Sistermans, Ben A. Oostra, B. B. A. De Vries, Rob Willemsen
Přispěvatelé: Human genetics, Amsterdam Reproduction & Development (AR&D), Clinical Genetics
Rok vydání: 1997
Předmět:
Zdroj: Human Genetics, 99, 3, pp. 308-311
Human Genetics, 99(3), 308-311. Springer Verlag
Human Genetics, 99, 308-311. Springer-Verlag
Human Genetics, 99, 308-311
Human Genetics, 99, pp. 308-311
Willemsen, R, Smits, A, Mohkamsing, S, Van Beerendonk, H, De Haan, A, De Vries, B, Van Den Ouweland, A, Sistermans, E, Galjaard, H & Oostra, B A 1997, ' Rapid antibody test for diagnosing fragile X syndrome : A validation of the technique ', Human Genetics, vol. 99, no. 3, pp. 308-311 . https://doi.org/10.1007/s004390050363
ISSN: 1432-1203
0340-6717
DOI: 10.1007/s004390050363
Popis: To date, the identification of patients and carriers of the fragile X syndrome has been carried out by DNA analysis by means of the polymerase chain reaction and Southern blot analysis. This direct DNA analysis allows both the size of the CGG repeat and methylation status of the FMR1 gene to be determined. We have recently presented a rapid antibody test on blood smears based on the presence of FMRP, the protein product of the FMR1 gene, in lymphocytes from normal individuals and the absence of FMRP in lymphocytes from patients. Here, we have tested the diagnostic value of this new technique by studying FMRP expression in 173 blood smears from normal individuals and fragile X patients. The diagnostic power of the antibody test is 'perfect' for males, whereas the results are less specific for females.
Databáze: OpenAIRE